Gut microbiota dysbiosis is associated with altered tryptophan metabolism and dysregulated inflammatory response in severe COVID-19
Essex, M.; Pascual-Leone, B. M.; Löber, U.; Kuhring, M.; Zhang, B.; Bruening, U.; Fritsche-Guenther, R.; Krzanowski, M.; Vernengo, F. F.; Brumhard, S.; Röwekamp, I.; Bielecka, A. A.; Lesker, T. R.; Wyler, E.; Landthaler, M.; Mantei, A.; Meisel, C.; Caesar, S.; Thiebeault, C.; Corman, V.; Marko, L.; Suttorp, N.; Strowig, T.; Kurth, F.; Sander, L. E.; Li, Y.; Kirwan, J. A.; Forslund, S. K.; Opitz, B.
Show abstract
The clinical course of the 2019 coronavirus disease (COVID-19) is variable and to a substantial degree still unpredictable, especially in persons who have neither been vaccinated nor recovered from previous infection. We hypothesized that disease progression and inflammatory responses were associated with alterations in the microbiome and metabolome. To test this, we integrated metagenome, metabolome, cytokine, and transcriptome profiles of longitudinally collected samples from hospitalized COVID-19 patients at the beginning of the pandemic (before vaccines or variants of concern) and non-infected controls, and leveraged detailed clinical information and post-hoc confounder analysis to identify robust within- and cross-omics associations. Severe COVID-19 was directly associated with a depletion of potentially beneficial intestinal microbes mainly belonging to Clostridiales, whereas oropharyngeal microbiota disturbance appeared to be mainly driven by antibiotic use. COVID-19 severity was also associated with enhanced plasma concentrations of kynurenine, and reduced levels of various other tryptophan metabolites, lysophosphatidylcholines, and secondary bile acids. Decreased abundance of Clostridiales potentially mediated the observed reduction in 5-hydroxytryptophan levels. Moreover, altered plasma levels of various tryptophan metabolites and lower abundances of Clostridiales explained significant increases in the production of IL-6, IFN{gamma} and/or TNF. Collectively, our study identifies correlated microbiome and metabolome alterations as a potential contributor to inflammatory dysregulation in severe COVID-19. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=150 HEIGHT=200 SRC="FIGDIR/small/518860v1_ufig1.gif" ALT="Figure 1"> View larger version (48K): org.highwire.dtl.DTLVardef@afc4edorg.highwire.dtl.DTLVardef@1a9ac2aorg.highwire.dtl.DTLVardef@65fb46org.highwire.dtl.DTLVardef@153ee6a_HPS_FORMAT_FIGEXP M_FIG C_FIG
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Biosynthetic Enzyme-guided Disease Correlation Connects Gut Microbial Metabolites Sulfonolipids to Inflammatory Bowel Disease Involving TLR4 Signaling 97%
- Disease-specific loss of microbial cross-feeding interactions in the human gut 97%
- Mechanical ventilation affects respiratory microbiome of COVID-19 patients and its interactions with the host 96%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Fetal programming by the parental microbiome of offspring behavior, and DNA methylation and gene expression within the hippocampus 97%
- Transplantation of bacteriophages from ulcerative colitis patients shifts the gut bacteriome and exacerbates severity of DSS-colitis 96%
- The interplay between host genetics and the gut microbiome reveals common and distinct microbiome features for human complex diseases 96%
Similar papers in this journal
- Genome-microbiome interplay provides insight into the determinants of the human blood metabolome 97%
- The cellular states and fates of shed intestinal cells 95%
- Short-chain fatty acid metabolites propionate and butyrate are unique epigenetic regulatory elements linking diet, metabolism and gene expression 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.